Please use this identifier to cite or link to this item:
doi:10.22028/D291-39206
Title: | Local Application of Mineral-Coated Microparticles Loaded With VEGF and BMP-2 Induces the Healing of Murine Atrophic Non-Unions |
Author(s): | Orth, M. Fritz, T. Stutz, J. Scheuer, C. Ganse, B. Bullinger, Y. Lee, J. S. Murphy, W. L. Laschke, M. W. Menger, M. D. Pohlemann, T. |
Language: | English |
Title: | Frontiers in Bioengineering and Biotechnology |
Volume: | 9 |
Publisher/Platform: | Frontiers |
Year of Publication: | 2022 |
Free key words: | non-union mineral-coated microparticles VEGF BMP-2 bone healing fracture |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | Deficient angiogenesis and disturbed osteogenesis are key factors for the development of nonunions. Mineral-coated microparticles (MCM) represent a sophisticated carrier system for the delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)-2. In this study, we investigated whether a combination of VEGF- and BMP2-loaded MCM (MCM + VB) with a ratio of 1:2 improves bone repair in non-unions. For this purpose, we applied MCM + VB or unloaded MCM in a murine non-union model and studied the process of bone healing by means of radiological, biomechanical, histomorphometric, immunohistochemical and Western blot techniques after 14 and 70 days. MCM-free non-unions served as controls. Bone defects treated with MCM + VB exhibited osseous bridging, an improved biomechanical stiffness, an increased bone volume within the callus including ongoing mineralization, increased vascularization, and a histologically larger total periosteal callus area consisting predominantly of osseous tissue when compared to defects of the other groups. Western blot analyses on day 14 revealed a higher expression of osteoprotegerin (OPG) and vice versa reduced expression of receptor activator of NF-κB ligand (RANKL) in bone defects treated with MCM + VB. On day 70, these defects exhibited an increased expression of erythropoietin (EPO), EPOreceptor and BMP-4. These findings indicate that the use of MCM for spatiotemporal controlled delivery of VEGF and BMP-2 shows great potential to improve bone healing in atrophic non-unions by promoting angiogenesis and osteogenesis as well as reducing early osteoclast activity. |
DOI of the first publication: | 10.3389/fbioe.2021.809397 |
URL of the first publication: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.809397 |
Link to this record: | urn:nbn:de:bsz:291--ds-392064 hdl:20.500.11880/35335 http://dx.doi.org/10.22028/D291-39206 |
ISSN: | 2296-4185 |
Date of registration: | 3-Mar-2023 |
Faculty: | M - Medizinische Fakultät |
Department: | M - Chirurgie M - Neurochirurgie |
Professorship: | M - Prof. Dr. med. Bergita Ganse M - Prof. Dr. Michael D. Menger M - Prof. Dr. Joachim Oertel M - Prof. Dr. Tim Pohlemann |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
fbioe-09-809397.pdf | 4,06 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License